Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001387131-19-001904
Filing Date
2019-03-13
Accepted
2019-03-13 17:31:05
Documents
57
Period of Report
2016-02-29

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT plsi-10k_022916.htm 10-K 568876
2 CERTIFICATIONS ex31-1.htm EX-31.1 14596
3 CERTIFICATIONS ex31-2.htm EX-31.2 14115
4 CERTIFICATIONS ex32-1.htm EX-32.1 5740
5 CERTIFICATIONS ex32-2.htm EX-32.2 6186
12 GRAPHIC img_001.jpg GRAPHIC 24285
13 GRAPHIC img_002.jpg GRAPHIC 9308
  Complete submission text file 0001387131-19-001904.txt   3230225

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT plsi-20160229.xml EX-101.INS 359077
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT plsi-20160229.xsd EX-101.SCH 45666
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT plsi-20160229_cal.xml EX-101.CAL 45471
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT plsi-20160229_def.xml EX-101.DEF 207415
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT plsi-20160229_lab.xml EX-101.LAB 308688
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT plsi-20160229_pre.xml EX-101.PRE 256301
Mailing Address 3000 LAWRENCE STREET DENVER CO 80205
Business Address 3000 LAWRENCE STREET DENVER CO 80205 1.720.699.7222
Phoenix Life Sciences International Limited. (Filer) CIK: 0001493212 (see all company filings)

EIN.: 460525378 | State of Incorp.: NV | Fiscal Year End: 0228
Type: 10-K | Act: 34 | File No.: 333-167275 | Film No.: 19679090
SIC: 1311 Crude Petroleum & Natural Gas